Arpeggio Bio
Leah received her PhD in Biochemistry from the University of Colorado where she used microscopy and genomics to study the role of zinc in transcriptional regulation. Prior to grad school, Leah worked at MA General Hospital where she screened cancer cell lines to identify novel therapeutics. At Arpeggio, Leah focuses on scaling and automating drug screening efforts.
Arpeggio Bio
Arpeggio Bio's technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment.